Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)

17.22
Delayed Data
As of Jul 21
 +0.22 / +1.29%
Today’s Change
12.48
Today|||52-Week Range
19.94
+12.62%
Year-to-Date

Today’s Trading

Previous close17.00
Today’s open17.00
Day’s range16.79 - 17.33
Volume2,810,246
Average volume (3 months)1,236,928
Market cap$2.6B
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)+44.00%
Earnings growth (this year)-72.16%
Earnings growth (next 5 years)+55.00%
Revenue growth (last year)+83.18%
P/E ratioNM
Price/Sales8.09
Price/Book37.97

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...-0.30-0.44%
LGNDLigand Pharmaceutica...+2.36+1.96%
SRPTSarepta Therapeutics...+2.48+6.06%
PBHPrestige Brands Hold...+0.13+0.25%
Data as of 4:02pm ET, 07/21/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$274.0M
Annual profit (last year)-$81.7M
Net profit margin-29.83%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Peter M. Hecht
Chief Financial Officer &
SVP-Corporate Strategy
Thomas Graney
Corporate headquarters
Cambridge, Massachusetts

Forecasts